Your session is about to expire
← Back to Search
Study Summary
This trial will have two substudies - Substudy A and Substudy B. Substudy A will look at the safety and immunogenicity of different influenza vaccines in people aged 65-85, while Substudy B will look at different vaccination schedules in people aged 65-85.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Is it possible to sign up for this trial currently?
"Yes, this is an active trial according to the information available on clinicaltrials.gov. The listing says that the study was first posted on 9/13/2021 and last updated on 10/18/2022. They are looking for a total of 1980 patients at 100 different sites."
How can I sign up to be a test subject for this research?
"This trial is looking for 1980 participants aged 18 to 85 who have influenza. Additionally, patients must meet the following criteria: Substudy A – Participants who are willing and able to comply with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations, and other study procedures., Healthy participants who are determined by medical history, physical examination (if required), and clinical judgment of the investigator to be eligible for inclusion in the study., Capable of giving signed informed consent., Male or female participants 65 to 85 years of age., Male participant who is able to father children and willing to use an acceptable method of contraception; or female participant not"
What difference do researchers expect this study will make?
"The purpose of this clinical trial is to assess the percentage of participants reporting systemic events (between the ages of 18 and 64, as well as 65 and 85) over a one-week period after receiving vaccination. Additionally, secondary outcomes being monitored include geometric mean titers (GMTs) of hemagglutination inhibition (HAI) – which will be measured at central laboratories – for participants aged 65 to 85, as well as the proportion of participants in this age group who achieve HAI seroconversion for each strain."
Does this study allow elderly patients to participate?
"According to the inclusion criteria found on this clinical trial's website, patients must be aged 18 to 85. There are currently 39 trials ongoing for individuals who are under 18 and 76 studies for people over the age of 65."
How many test subjects are in this clinical trial?
"To successfully complete this clinical trial, 1980 eligible individuals are required to participate. Patients can choose to partake in this study at different sites such as Invesclinic US LLC located in Davie, Florida and Meridian Clinical Research LLC based in Omaha, Nebraska."
Are there any other research facilities besides those in North America conducting this experiment?
"100 different research facilities are conducting this study, like Invesclinic US LLC in Davie, Meridian Clinical Research LLC in Omaha, Progressive Medical Research in Port Orange, and many others."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger